For research use only
| Cat No. | ABC-SC0038T |
| Product Type | Human Mesenchymal Stem Cells |
| Cell Type | Mesenchymal Stem Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Umbilical Cord Matrix |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Advance stem cell research with HighQC™ Human Mesenchymal Stem Cell (Umbilical Cord Matrix/Cell Pellet In RNAlater) for regenerative applications.
HighQC™ Human Mesenchymal Stem Cells (Umbilical Cord Matrix/ Cell Pellet In RNAlater) are derived from the gelatinous connective tissue of normal human umbilical cord matrix. These cells exhibit characteristics of mesenchymal stem cells, including self-renewal and the ability to differentiate into various cell types like cardiomyocytes, neuron-like cells, osteocytes, endothelial cells, and pancreatic islet-like cell clusters. This product is preserved in RNAlater, ensuring optimal stabilization of RNA and proteins for downstream molecular analysis. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
| Product Code | HighQC™ Human Mesenchymal Stem Cell (Umbilical Cord Matrix/ Cell Pellet In RNAlater), Human UC-MSC-RNA, hUC-MSC-RNA, Human Umbilical Cord MSC RNAlater |
| Species | Human |
| Cat.No | ABC-SC0038T |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Mesenchymal Stem Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Umbilical Cord Matrix |
| Disease | Normal |
| Storage | Liquid Nitrogen |
| Product Type | Human Mesenchymal Stem Cells |
HighQC™ Human Mesenchymal Stem Cells (Umbilical Cord Matrix/ Cell Pellet In RNAlater) serve as an in vitro model for studying mesenchymal stem cell differentiation mechanisms, and drug screening. Their preserved molecular integrity enables detailed gene expression profiling, supporting the elucidation of therapeutic mechanisms and the development of targeted cell-based therapies.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).